Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
12:01:58 24/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 377.86 USD | -0.45% |
|
+0.17% | +25.31% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 10,076 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 22.69% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,327 | 9,110 | 8,969 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 18.44% | -2.32% | -1.55% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 45.6x | 44.6x | 44.9x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.7x | 19.53x | -63.68x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.92x | 3.83x | 3.76x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.62x | 3.46x | 3.34x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 22.7x | 20.9x | 20.1x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 32.4x | 28.6x | 27.3x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 30.4x | 28.8x | 27.1x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.29% | 3.47% | 3.69% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,573 | 2,633 | 2,682 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 410.3 | 435.1 | 446.5 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 287.5 | 318.4 | 328.8 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 379.57 | 379.57 | 379.57 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 10/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 45.62x | 3.62x | 22.73x | -.--% | 1.01TCr | |
| 29.38x | 4.05x | 15.66x | 2.48% | 18TCr | |
| 19.2x | 3.51x | 12.56x | 3.1% | 12TCr | |
| 17.22x | 0.2x | 12.61x | 0.76% | 6TCr | |
| 35.27x | 3.41x | 11.68x | 2.14% | 4.98TCr | |
| 27.56x | 6.78x | 17.54x | 1.45% | 4.8TCr | |
| 35.89x | 6.31x | 19.82x | -.--% | 3.38TCr | |
| 44.45x | 1.29x | 11.95x | 0.21% | 3.02TCr | |
| 43.27x | 7.59x | 27.23x | 0.24% | 2.61TCr | |
| 52.64x | 7.06x | 22.71x | 0.4% | 2.3TCr | |
| Average | 35.05x | 4.38x | 17.45x | 1.08% | 5.77TCr | |
| Weighted average by Cap. | 29.43x | 3.98x | 15.51x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
